2018930

Other Tomoyuki Kikugawa was appointed as External Auditor (full-time)

2018918

PR Heartseed Inc. was selected as one of the subsidy program of Japan Agency for Medical Research and Development (AMED), supporting Research Project for Practical Applications of Regenerative Medicine

2018730

PR Announced that 800 million yen was raised through third-party allocation of new shares from Angel Bridge, Astellas Venture Management and Shibuya Cooperation